 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
Volume 17, Number 4, Issue of February 15, 1997 pp. 1271-1281
Copyright ©1997 Society for NeuroscienceDisruption of the Metallothionein-III Gene in Mice: Analysis of Brain Zinc, Behavior, and Neuron Vulnerability to Metals, Aging, and Seizures
Received Aug. 5, 1996; revised Oct. 28, 1996; accepted Dec. 3, 1996.
Jay C. Erickson, Gunther Hollopeter, Steven A. Thomas, Glenda J. Froelick, and Richard D. Palmiter The Howard Hughes Medical Institute and Department of Biochemistry, University of Washington, Seattle, Washington 98195-7370
Metallothionein-III (MT-III), a brain-specific member of the metallothionein family of metal-binding proteins, is abundant in glutamatergic neurons that release zinc from their synaptic terminals, such as hippocampal pyramidal neurons and dentate granule cells. MT-III may be an important regulator of zinc in the nervous system, and its absence has been implicated in the development of Alzheimer's disease. However, the roles of MT-III in brain physiology and pathophysiology have not been elucidated. Mice lacking MT-III because of targeted gene inactivation were generated to evaluate the neurobiological significance of MT-III. MT-III-deficient mice had decreased concentrations of zinc in several brain regions, including hippocampus, but the pool of histochemically reactive zinc was not disturbed. Mutant mice exhibited normal spatial learning in the Morris water maze and were not sensitive to systemic zinc or cadmium exposure. No neuropathology or behavioral deficits were detected in 2-year-old MT-III-deficient mice, but the age-related increase in glial fibrillary acidic protein expression was more pronounced in mutant brain. MT-III-deficient mice were more susceptible to seizures induced by kainic acid and subsequently exhibited greater neuron injury in the CA3 field of hippocampus. Conversely, transgenic mice containing elevated levels of MT-III were more resistant to CA3 neuron injury induced by seizures. These observations suggest a potential role for MT-III in zinc regulation during neural stimulation.
Key words: metallothionein; zinc; seizures; kainic acid; hippocampus; cadmium; Morris water maze; glial fibrillary acidic protein; Alzheimer's disease; zinc-containing neurons
This article has been cited by other articles:
H. G. Kim, Y. P. Hwang, E. H. Han, C. Y. Choi, C.-Y. Yeo, J. Y. Kim, K. Y. Lee, and H. G. Jeong
Metallothionein-III Provides Neuronal Protection through Activation of Nuclear Factor-{kappa}B via the TrkA/Phosphatidylinositol-3 kinase/Akt Signaling Pathway
Toxicol. Sci., December 1, 2009; 112(2): 435 - 449.
[Abstract] [Full Text] [PDF]
J. P. Wu, B. Y. Ma, H. W. Ren, L. P. Zhang, Y. Xiang, and M. A. Brown
Characterization of metallothioneins (MT-I and MT-II) in the yak
J Anim Sci, June 1, 2007; 85(6): 1357 - 1362.
[Abstract] [Full Text] [PDF]
J. Hidalgo, M. Penkowa, C. Espejo, E. M. Martinez-Caceres, J. Carrasco, A. Quintana, A. Molinero, S. Florit, M. Giralt, and A. Ortega-Aznar
Expression of Metallothionein-I, -II, and -III in Alzheimer Disease and Animal Models of Neuroinflammation.
Experimental Biology and Medicine, October 1, 2006; 231(9): 1450 - 1458.
[Abstract] [Full Text] [PDF]
I. El Ghazi, B. L. Martin, and I. M. Armitage
Metallothionein-3 is a component of a multiprotein complex in the mouse brain.
Experimental Biology and Medicine, October 1, 2006; 231(9): 1500 - 1506.
[Abstract] [Full Text] [PDF]
D. Religa, D. Strozyk, R. A. Cherny, I. Volitakis, V. Haroutunian, B. Winblad, J. Naslund, and A. I. Bush
Elevated cortical zinc in Alzheimer disease.
Neurology, July 11, 2006; 67(1): 69 - 75.
[Abstract] [Full Text] [PDF]
A. Cote, M. Chiasson, M. R Peralta III, K. Lafortune, L. Pellegrini, and K. Toth
Cell type-specific action of seizure-induced intracellular zinc accumulation in the rat hippocampus
J. Physiol., August 1, 2005; 566(3): 821 - 837.
[Abstract] [Full Text] [PDF]
H. G. Jeong, C.-K. Youn, H.-J. Cho, S.-H. Kim, M.-H. Kim, H.-B. Kim, I.-Y. Chang, Y.-S. Lee, M.-H. Chung, and H. J. You
Metallothionein-III Prevents {gamma}-Ray-induced 8-Oxoguanine Accumulation in Normal and hOGG1-depleted Cells
J. Biol. Chem., August 13, 2004; 279(33): 34138 - 34149.
[Abstract] [Full Text] [PDF]
Y. WANG, U. WIMMER, P. LICHTLEN, D. INDERBITZIN, B. STIEGER, P. J. MEIER, L. HUNZIKER, T. STALLMACH, R. FORRER, T. RULICKE, et al.
Metal-responsive transcription factor-1 (MTF-1) is essential for embryonic liver development and heavy metal detoxification in the adult liver
FASEB J, July 1, 2004; 18(10): 1071 - 1079.
[Abstract] [Full Text] [PDF]
Q. Zheng, W.-M. Yang, W.-H. Yu, B. Cai, X.-C. Teng, Y. Xie, H.-Z. Sun, M.-J. Zhang, and Z.-X. Huang
The effect of the EAAEAE insert on the property of human metallothionein-3
Protein Eng. Des. Sel., December 1, 2003; 16(12): 865 - 870.
[Abstract] [Full Text] [PDF]
S. C. Burdette and S. J. Lippard
Bioinorganic Chemistry Special Feature: Meeting of the minds: Metalloneurochemistry
PNAS, April 1, 2003; 100(7): 3605 - 3610.
[Abstract] [Full Text] [PDF]
M. Yamashita, E. Glasgow, B.-J. Zhang, K. Kusano, and H. Gainer
Identification of Cell-Specific Messenger Ribonucleic Acids in Oxytocinergic and Vasopressinergic Magnocellular Neurons in Rat Supraoptic Nucleus by Single-Cell Differential Hybridization
Endocrinology, November 1, 2002; 143(11): 4464 - 4476.
[Abstract] [Full Text] [PDF]
K. Puttaparthi, W. L. Gitomer, U. Krishnan, M. Son, B. Rajendran, and J. L. Elliott
Disease Progression in a Transgenic Model of Familial Amyotrophic Lateral Sclerosis Is Dependent on Both Neuronal and Non-Neuronal Zinc Binding Proteins
J. Neurosci., October 15, 2002; 22(20): 8790 - 8796.
[Abstract] [Full Text] [PDF]
N. Romero-Isart, L. T. Jensen, O. Zerbe, D. R. Winge, and M. Vasak
Engineering of Metallothionein-3 Neuroinhibitory Activity into the Inactive Isoform Metallothionein-1
J. Biol. Chem., September 27, 2002; 277(40): 37023 - 37028.
[Abstract] [Full Text] [PDF]
Y. Uchida, F. Gomi, T. Masumizu, and Y. Miura
Growth Inhibitory Factor Prevents Neurite Extension and the Death of Cortical Neurons Caused by High Oxygen Exposure through Hydroxyl Radical Scavenging
J. Biol. Chem., August 23, 2002; 277(35): 32353 - 32359.
[Abstract] [Full Text] [PDF]
C. J. Frederickson, S. W. Suh, D. Silva, C. J. Frederickson, and R. B. Thompson
Importance of Zinc in the Central Nervous System: The Zinc-Containing Neuron
J. Nutr., May 1, 2000; 130(5): 1471S - 1483.
[Abstract] [Full Text]
R. A. Colvin, N. Davis, R. W. Nipper, and P. A. Carter
Zinc Transport in the Brain: Routes of Zinc Influx and Efflux in Neurons
J. Nutr., May 1, 2000; 130(5): 1484S - 1487.
[Abstract] [Full Text]
H. H. Sandstead, C. J. Frederickson, and J. G. Penland
History of Zinc as Related to Brain Function
J. Nutr., February 1, 2000; 130(2): 496 - 496.
[Abstract] [Full Text]
M. van Lookeren Campagne, H. Thibodeaux, N. van Bruggen, B. Cairns, R. Gerlai, J. T. Palmer, S. P. Williams, and D. G. Lowe
Evidence for a protective role of metallothionein-1 in focal cerebral ischemia
PNAS, October 26, 1999; 96(22): 12870 - 12875.
[Abstract] [Full Text] [PDF]
T. B. Cole, H. J. Wenzel, K. E. Kafer, P. A. Schwartzkroin, and R. D. Palmiter
Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene
PNAS, February 16, 1999; 96(4): 1716 - 1721.
[Abstract] [Full Text] [PDF]
S. L. Sensi, L. M. T. Canzoniero, S. P. Yu, H. S. Ying, J.-Y. Koh, G. A. Kerchner, and D. W. Choi
Measurement of Intracellular Free Zinc in Living Cortical Neurons: Routes of Entry
J. Neurosci., December 15, 1997; 17(24): 9554 - 9564.
[Abstract] [Full Text] [PDF]
S. F. Kash, R. S. Johnson, L. H. Tecott, J. L. Noebels, R. D. Mayfield, D. Hanahan, and S. Baekkeskov
Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase
PNAS, December 9, 1997; 94(25): 14060 - 14065.
[Abstract] [Full Text] [PDF]
R. A. Colvin
pH dependence and compartmentalization of zinc transported across plasma membrane of rat cortical neurons
Am J Physiol Cell Physiol, February 1, 2002; 282(2): C317 - C329.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|